Found: 28
Select item for more details and to access through your institution.
Dual Bronchodilator Therapy as First-Line Treatment in Maintenance-Naïve Patients with Symptomatic COPD: A Pre-Specified Analysis of the EMAX Trial.
- Published in:
- International Journal of COPD, 2021, v. 16, p. 1939, doi. 10.2147/COPD.S291751
- By:
- Publication type:
- Article
Treatment of COPD with Long-Acting Bronchodilators: Association Between Early and Longer-Term Clinically Important Improvement.
- Published in:
- International Journal of COPD, 2021, v. 16, p. 1215, doi. 10.2147/COPD.S295835
- By:
- Publication type:
- Article
Long-term cost and utility consequences of short-term clinically important deterioration in patients with chronic obstructive pulmonary disease: results from the TORCH study.
- Published in:
- International Journal of COPD, 2019, v. 14, p. 939, doi. 10.2147/COPD.S188898
- By:
- Publication type:
- Article
Prevention of clinically important deteriorations in COPD with umeclidinium/vilanterol.
- Published in:
- International Journal of COPD, 2016, v. 11, p. 1413, doi. 10.2147/copd.s101612
- By:
- Publication type:
- Article
Correction to: Measuring disease activity in COPD: is clinically important deterioration the answer?
- Published in:
- 2021
- By:
- Publication type:
- corrected article
The effect of budesonide/formoterol maintenance and reliever therapy on the risk of severe asthma exacerbations following episodes of high reliever use: an exploratory analysis of two randomised, controlled studies with comparisons to standard therapy.
- Published in:
- Respiratory Research, 2012, v. 13, n. 7, p. 1, doi. 10.1186/1465-9921-13-59
- By:
- Publication type:
- Article
The effect of budesonide/formoterol maintenance and reliever therapy on the risk of severe asthma exacerbations following episodes of high reliever use: an exploratory analysis of two randomised, controlled studies with comparisons to standard therapy.
- Published in:
- 2012
- By:
- Publication type:
- journal article
Long-term outcomes following first short-term clinically important deterioration in COPD.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Rescue medication use as a patient-reported outcome in COPD: a systematic review and regression analysis.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Impact of baseline COPD symptom severity on the benefit from dual versus mono-bronchodilators: an analysis of the EMAX randomised controlled trial.
- Published in:
- Therapeutic Advances in Respiratory Disease, 2020, p. 1, doi. 10.1177/1753466620968500
- By:
- Publication type:
- Article
Early and sustained symptom improvement with umeclidinium/vilanterol versus monotherapy in COPD: a post hoc analysis of the EMAX randomised controlled trial.
- Published in:
- Therapeutic Advances in Respiratory Disease, 2020, v. 14, p. 1, doi. 10.1177/1753466620926949
- By:
- Publication type:
- Article
Impact of baseline COPD symptom severity on the benefit from dual versus mono-bronchodilators: an analysis of the EMAX randomised controlled trial.
- Published in:
- Therapeutic Advances in Respiratory Disease, 2020, p. 1, doi. 10.1177/1753466620968500
- By:
- Publication type:
- Article
Early and sustained symptom improvement with umeclidinium/vilanterol versus monotherapy in COPD: a post hoc analysis of the EMAX randomised controlled trial.
- Published in:
- Therapeutic Advances in Respiratory Disease, 2020, p. 1, doi. 10.1177/1753466620926949
- By:
- Publication type:
- Article
How can the findings of the EMAX trial on long-acting bronchodilation in chronic obstructive pulmonary disease be applied in the primary care setting?
- Published in:
- Chronic Respiratory Disease, 2023, v. 20, p. 1, doi. 10.1177/14799731231202257
- By:
- Publication type:
- Article
How can the findings of the EMAX trial on long-acting bronchodilation in chronic obstructive pulmonary disease be applied in the primary care setting?
- Published in:
- Chronic Respiratory Disease, 2023, v. 20, p. 1, doi. 10.1177/14799731231202257
- By:
- Publication type:
- Article
Measuring disease activity in COPD: is clinically important deterioration the answer?
- Published in:
- 2020
- By:
- Publication type:
- journal article
Efficacy of umeclidinium/vilanterol versus umeclidinium and salmeterol monotherapies in symptomatic patients with COPD not receiving inhaled corticosteroids: the EMAX randomised trial.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Impact of prior and concurrent medication on exacerbation risk with long-acting bronchodilators in chronic obstructive pulmonary disease: a post hoc analysis.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Umeclidinium/Vilanterol Versus Tiotropium/Olodaterol in Maintenance-Naïve Patients with Moderate Symptomatic Chronic Obstructive Pulmonary Disease: A Post Hoc Analysis.
- Published in:
- Pulmonary Therapy, 2018, v. 4, n. 2, p. 171, doi. 10.1007/s41030-018-0057-7
- By:
- Publication type:
- Article
A Network Meta-Analysis of Long-Acting Muscarinic Antagonist (LAMA) and Long-Acting β-Agonist (LABA) Combinations in COPD.
- Published in:
- Pulmonary Therapy, 2017, v. 3, n. 2, p. 297, doi. 10.1007/s41030-017-0048-0
- By:
- Publication type:
- Article
Prevalence and Burden of Dyspnoea Among Patients with Chronic Obstructive Pulmonary Disease in Five European Countries.
- Published in:
- Pulmonary Therapy, 2016, v. 2, n. 1, p. 59, doi. 10.1007/s41030-016-0011-5
- By:
- Publication type:
- Article
Triple Therapy of Umeclidinium + Inhaled Corticosteroids/Long-Acting Beta Agonists for Patients with COPD: Pooled Results of Randomized Placebo-Controlled Trials.
- Published in:
- Pulmonary Therapy, 2016, v. 2, n. 1, p. 43, doi. 10.1007/s41030-016-0012-4
- By:
- Publication type:
- Article
Treatment preferences of adolescent patients with asthma.
- Published in:
- Pediatric Allergy & Immunology, 2000, v. 11, n. 1, p. 49, doi. 10.1034/j.1399-3038.2000.00043.x
- By:
- Publication type:
- Article
Efficacy of Umeclidinium/Vilanterol in Elderly Patients with COPD: A Pooled Analysis of Randomized Controlled Trials.
- Published in:
- Drugs & Aging, 2018, v. 35, n. 7, p. 637, doi. 10.1007/s40266-018-0558-y
- By:
- Publication type:
- Article
Preventing Clinically Important Deterioration of COPD with Addition of Umeclidinium to Inhaled Corticosteroid/Long-Acting β<sub>2</sub>-Agonist Therapy: An Integrated Post Hoc Analysis.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Comparative Efficacy of Once-Daily Umeclidinium/Vilanterol and Tiotropium/Olodaterol Therapy in Symptomatic Chronic Obstructive Pulmonary Disease: A Randomized Study.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Assessing Short-term Deterioration in Maintenance-naïve Patients with COPD Receiving Umeclidinium/Vilanterol and Tiotropium: A Pooled Analysis of Three Randomized Trials.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Cost-effectiveness of umeclidinium compared with tiotropium and glycopyrronium as monotherapy for chronic obstructive pulmonary disease: a UK perspective.
- Published in:
- Cost Effectiveness & Resource Allocation, 2018, v. 16, n. 1, p. N.PAG, doi. 10.1186/s12962-018-0101-3
- By:
- Publication type:
- Article